The emerging role of monitoring serum HER-2/neu oncoprotein levels in women with metastatic breast cancer

被引：12

作者：

Carney, WP ^{[1
]}

机构：

[1] Oncogene Sci, Cambridge, MA USA

来源：

LABORATORY MEDICINE | 2003年 / 34卷 / 01期

关键词：

D O I：

10.1309/TY6M-DWB0-G2BU-6D5F

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

The HER-2/neu oncogene encodes a transmembrane growth factor receptor protein that is overexpressed in a variety of cancer cells. The HER-2/neu oncoprotein has become a major target for the development of new cancer therapies. Studies show that monitoring serum HER-2/neu levels during metastatic breast cancer can provide a real-time assessment of a woman's HER-2/neu status and can provide important information for making therapeutic decisions.

引用

页码：58 / 64

页数：7